Literature DB >> 9286030

Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma.

K Tanabe1, S C Campbell, J P Alexander, F Steinbach, M G Edinger, R R Tubbs, A C Novick, E A Klein.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) mediates two important functional aspects of tumor biology, namely enhancement of tumor metastasis and mediation of host defense mechanisms such as lymphocyte-mediated tumor cytotoxicity. Since ICAM-1 is expressed by most renal cell carcinomas (RCC), the regulation of ICAM-1 expression is important in understanding the biological behavior of RCC. We report an investigation on ICAM-1 expression and molecular regulation by cytokines and protein kinase C activator on RCC cell lines. Of the various cytokines, tumor necrosis factor alpha (TNF alpha), interferon-gamma (IFN gamma), and phorbol myristate acetate (PMA) strongly upregulated ICAM-1 protein expression on RCC. The kinetics of ICAM-1 message induction was studied by Northern analysis of total RNA extracted from RCC and normal kidney proximal tubular (NKPT) cells. Time course studies showed that ICAM-1 mRNA was upregulated by INF gamma, TNF alpha, and PMA, plateaued after 2 h, and remained increased for up to 24 h. Although ICAM-1 mRNA in NKPT cells was upregulated by these cytokines, their messages returned to basal levels after 24 h. ICAM-1 mRNA stability assays showed that both unstimulated and stimulated RCC cells had very stable ICAM-1 mRNA up to 24 h. In order to investigate whether increased gene transcription contributes to ICAM-1 upregulation, RCC cells were treated with TNF alpha, IFN gamma, or PMA with or without simultaneous addition of actinomycin D. ICAM-1 message induction-blocking studies suggested that primary upregulation of ICAM-1 mRNA may be caused by transcriptional upregulation. These results suggest that long-lasting ICAM-1 message upregulation in response to cytokines or PMA may be due to transcriptional upregulation in the early phase and stabilization of ICAM-1 message in the later phase (after 4 h). These observations suggest that RCC may lack the normal downregulatory mechanisms which control ICAM-1 expression and may explain the high frequency of ICAM-1 expression observed on primary human RCC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286030     DOI: 10.1007/bf00942091

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  9 in total

1.  Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha.

Authors:  E Juengel; M Bhasin; T Libermann; S Barth; M Michaelis; J Cinatl; J Jones; L Hudak; D Jonas; R A Blaheta
Journal:  World J Urol       Date:  2010-07-17       Impact factor: 4.226

2.  Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.

Authors:  Shian-Shiang Wang; Ming-Ju Hsieh; Yen-Chuan Ou; Chuan-Shu Chen; Jian-Ri Li; Pei-Ching Hsiao; Shun-Fa Yang
Journal:  Tumour Biol       Date:  2014-05-02

3.  p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner.

Authors:  Vassilis G Gorgoulis; Panayotis Zacharatos; Athanassios Kotsinas; Dimitris Kletsas; George Mariatos; Vassilis Zoumpourlis; Kevin M Ryan; Christos Kittas; Athanasios G Papavassiliou
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

4.  Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma.

Authors:  Xuebing Shi; Jifa Jiang; Xiaobing Ye; Yanyan Liu; Qiong Wu; Lu Wang
Journal:  J Mol Histol       Date:  2014-02-18       Impact factor: 2.611

5.  Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7.

Authors:  F Steinbach; J Alexander; K Tanabe; R Troy; M G Edinger; R R Tubbs; J T McMahon; A C Novick; E A Klein
Journal:  Urol Res       Date:  1995

6.  Polymorphisms in the intercellular adhesion molecule 1 gene and cancer risk: a meta-analysis.

Authors:  Weifeng Tang; Yafeng Wang; Yuanmei Chen; Haiyong Gu; Shuchen Chen; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.

Authors:  F Laube; B Göhring; H Sann; I Willhardt
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

8.  Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity.

Authors:  Geom Seog Seo; Wen-Yi Jiang; Jin Hua Chi; Hao Jin; Won-Chul Park; Dong Hwan Sohn; Pil-Hoon Park; Sung Hee Lee
Journal:  Oncotarget       Date:  2015-08-14

9.  Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.

Authors:  Jinxing Wang; Lushun Yuan; Xingnian Liu; Gang Wang; Yuan Zhu; Kaiyu Qian; Yu Xiao; Xinghuan Wang
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.